The lived experiences of woman navigating university with lupus and their primary support persons [0.03%]
狼疮女性患者的大学生活及其主要支持人物的主要支持人物的亲身经历
Hailey A ONeil,Misha Behi,Paula C Fletcher
Hailey A ONeil
ObjectiveThis study examined the lived experiences of women with lupus and their primary support persons to better understand the effects associated with navigating university/college with lupus.MethodsFive women with lupus and five primary...
Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review [0.03%]
系统性红斑狼疮肺缩小综合征的治疗策略和临床结局:更新后的系统综述
Júlia Ribeiro Lemos,Agnaldo José Lopes,Patrícia Dos Santos Vigário
Júlia Ribeiro Lemos
BackgroundShrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus (SLE) lacking standardized management. This systematic review summarizes the current evidence on therapeutic interventions and clinical outcomes...
Skin involvement in the catastrophic antiphospholipid syndrome: A review from CAPS registry [0.03%]
灾难性抗磷脂综合征的皮肤受累:来自CAPS注册中心的综述
A Ponce,I Rodríguez-Pintó,I Pons et al.
A Ponce et al.
ObjectiveTo describe the prevalence, clinical manifestations, histopathological features, and antibody profile associated to skin involvement in patients with catastrophic antiphospholipid syndrome (CAPS).MethodsWe performed a cross-section...
Outcomes of systemic lupus erythematosus hospitalisations in Qatar: Insights from a multinational tertiary centre experience [0.03%]
卡塔尔系统性红斑狼疮住院患者的预后:一个跨国三级医疗中心的经验分析
Miral H Gharib,Karima Becetti,Hana J Abukhadijah et al.
Miral H Gharib et al.
ObjectiveSystemic lupus erythematosus (SLE) is a chronic autoimmune disorder associated with considerable morbidity and mortality, particularly due to frequent hospitalisations. This study aimed to describe the causes, clinical course, and ...
Comparative performance of lupus disease-activity indices during pregnancy to predict adverse obstetric outcomes: A colombian SLE cohort [0.03%]
与妊娠不良结局预测相关的狼疮疾病活动指数的比较性能:哥伦比亚SLE病人群数据分析
Jairo Cajamarca-Barón,Catalina Sanmiguel-Reyes,Juan Esteban Bedoya-Loaiza et al.
Jairo Cajamarca-Barón et al.
ObjectiveTo compare the performance of five lupus disease-activity indices measured at a single retrospective pregnancy timepoint for discriminating a composite adverse obstetric outcome (AO), and to perform exploratory clinically interpret...
Evaluating the readability and comprehension of patient education materials for Systemic Lupus Erythematosus (SLE) available online [0.03%]
评估系统性红斑狼疮(SLE)患者教育材料的可读性和理解度
Nagoor Shaik,Ugochukwu C Nweke,Meenakshi Jolly
Nagoor Shaik
ObjectiveWe evaluated the reading & comprehension levels of Systemic Lupus Erythematosus (SLE) Patient educational materials (PEMs) available online, from both nonprofit and for-profit organizations.MethodsWe analyzed PEMs from four nonprof...
Kidney outcomes in pure membranous versus proliferative lupus nephritis: A 14-year Latin American cohort study [0.03%]
一项14年拉丁美洲队列研究中的单纯膜性狼疮肾炎与增生性狼疮肾炎的肾脏转归情况
Joaquín Rodelo-Ceballos,Mauricio Restrepo-Escobar,Jose Ustariz et al.
Joaquín Rodelo-Ceballos et al.
BackgroundPure membranous lupus nephritis (MLN) generally has a better kidney prognosis than proliferative lupus nephritis (PLN), but comparative data from Latin America remain limited. We evaluated clinical features and kidney outcomes of ...
Deep immunological resetting in refractory systemic lupus erythematosus post-kidney transplantation: A longitudinal immunophenotypic analysis [0.03%]
肾移植后难治性系统性红斑狼疮的深度免疫重建:纵向免疫表型分析
Ru-Fang Zheng,Jeng-Wei Lu,Yi-Jung Ho et al.
Ru-Fang Zheng et al.
BackgroundA 66-year-old female with a 15-year history of refractory lupus nephritis, complicated by severe hypersplenism requiring splenectomy and 8 years of hemodialysis, successfully underwent deceased-donor kidney transplantation. Post-t...
A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic [0.03%]
在学术 lupus 诊所中结合霉酚酸风险管理策略的质量改进项目
Dahima Cintron,Caitlan Pinotti,Jennifer L Rogers et al.
Dahima Cintron et al.
Background/PurposeMycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal ...
From clinical to immunologic remission in lupus nephritis: Toward MRD-grade B-cell depletion [0.03%]
从狼疮性肾炎的临床缓解到免疫学缓解:向着MRD级B细胞耗竭发展
Lucas Maciel de Almeida Corrêa,Luiggi Kevin Virgino Brandão,Clara Belo Gamon Santiago et al.
Lucas Maciel de Almeida Corrêa et al.
Current B-cell depletion strategies in lupus nephritis (LN) may encounter a mechanistic "glass ceiling." While rituximab remains an important therapeutic option, its activity can be constrained by CD20 internalization, antigenic modulation,...